Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2007-12-18
2007-12-18
Paras, Jr., Peter (Department: 1632)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C435S320100, C435S325000
Reexamination Certificate
active
10142275
ABSTRACT:
This disclosure encompasses the edr3 polynucleotide, polypeptides encoded by the edr3 gene and fragments thereof. This disclosure also encompasses homologues of the edr3 gene from mammals, in particular from humans. In addition, this disclosure encompasses the use of edr3 polynucleotides, edr3 proteins and polypeptides, and antibodies to the edr3 protein capable of increasing or decreasing edr3 activity or expression.
REFERENCES:
patent: 4714681 (1987-12-01), Reading
patent: 4853230 (1989-08-01), Lovgren et al.
patent: 4946778 (1990-08-01), Ladner et al.
patent: 5093246 (1992-03-01), Cech et al.
patent: 5223409 (1993-06-01), Ladner et al.
patent: 5270163 (1993-12-01), Gold et al.
patent: 5270170 (1993-12-01), Schatz et al.
patent: 5283173 (1994-02-01), Fields et al.
patent: 5422120 (1995-06-01), Kim
patent: 5633135 (1997-05-01), Croce et al.
patent: 5633136 (1997-05-01), Croce et al.
patent: 5641670 (1997-06-01), Treco et al.
patent: 5698686 (1997-12-01), Gottschling et al.
patent: 5714353 (1998-02-01), Pathak et al.
patent: 5741486 (1998-04-01), Pathak et al.
patent: 5914266 (1999-06-01), Randazzo
patent: 5916752 (1999-06-01), Gottschling et al.
patent: 5935811 (1999-08-01), Anderson et al.
patent: 5948640 (1999-09-01), Randazzo
patent: 5955594 (1999-09-01), Mishra
patent: 6004528 (1999-12-01), Bergstein
patent: 6040140 (2000-03-01), Croce et al.
patent: 6060588 (2000-05-01), Li et al.
patent: 6083742 (2000-07-01), Randazzo
patent: 6096534 (2000-08-01), Barsov et al.
patent: 6103886 (2000-08-01), Lahn et al.
patent: 6140111 (2000-10-01), Riviere et al.
patent: 6140483 (2000-10-01), Randazzo
patent: 6166191 (2000-12-01), Randazzo
patent: 6190907 (2001-02-01), Kim et al.
patent: 6194557 (2001-02-01), Li et al.
patent: 0 524 968 (1991-03-01), None
patent: WO 92/06204 (1992-04-01), None
Stephen M. Edgington. “Is biopharmaceutical discovery entering a new evolutionary stage?” Bio/Technology. vol. 11. pp. 285-289. Mar. 1993.
Hansen, et al. “Osteosarcoma and retinoblastoma: A shared chromosomal mechanism revealing recessive predisposition”. Proc. Natl. Acad. Sci. USA. vol. 82. pp. 6216-6220. Sep. 1985.
Keppler-Noreull, et al. “Chromosome 18q Paracentric Inversion in a Family with Mental Retardation and Hearing Loss”. American Journal of Medical Genetics. vol. 76. pp. 372-378. (1998).
T. Ikeuchi. “Inhibitory effect of ethidium bromide on mitotic chromosome condensation and its application to high-resolution chromosome banding”. Cytogenet. Cell Genet. vol. 38, pp. 56-61 (1984).
Findeis, et al. “Targeted delivery of DNA for gene therapy via receptors”. Trends in Biotechnology. vol. 11. pp. 202-205 (1993).
Orlandi, et al. “Cloning immunoglobulin variable domains for expression by the polymerase chain reaction”. Proc. Natl. Acad. Sci. USA. vol. 86. pp. 3833-3837. May 1989.
Skerra, et al. “Assembly of a Functional Immunoglobullin Fv Fragment inEscherichia coli”.Science. vol. 240. pp. 1038-1041 (1998).
Better, et al. “Escherichia coliSecretion of an Active Chimeric Antibody Fragment”. Science vol. 240. pp. 1041-1043. (1988).
Sorge, et al.. “Amphotropic Retrovirus Vector System for Human Cell Gene Transfer”. Molecular and Cellular Biology. pp. vol. 4. No. 9. pp. 1730-1737. Sep. 1984.
Fred D. Ledley. “Pharmaceutical Approach to Somatic Gene Therapy”. Pharmaceutical Research. vol. 13. No. 11. pp. 1595-1614. 1996.
Wu, et al., “Receptor-mediated Gene Delivery and Expression in Vivo” The Journal of Biological Chemistry. vol. 263, No. 29, Issue of Oct. 15, 1988. pp. 14621-14624.
Wu, et al., “Receptor-mediated Gene Delivery in Vivo” The Journal of Biological Chemistry. vol. 266, No. 22 Issue of Aug. 5, 1991. pp. 14338-14342.
Wu, et al., “Incorporation of Adenovirus into a Ligand-based DNA Carrier System Results in Retention of Original Receptor Specificity and Enhances Targeted Gene Expression” The Journal of Biological Chemistry. vol. 269, No. 15, Issue of Apr. 15, 1994. pp. 11542-11546.
DeWitt, et al. ““Diversomers”: An approach to nonpeptide,nonoligomeric chemical diversity” Proc. Natl. Acad. Sci. USA. vol. 90, pp. 6909-6913, Aug. 1993.
Zenke, et al. “Receptor-mediated endocytosis of transferrin-polycation conjugates: An efficient way to introduce DNA into hematopoietic cells”. Proc. Natl. Acad. Sci. USA vol. 87, pp. 3655-3659, May 1990.
Cunningham, et al. “High-Resolution Epitope Mapping of hGH-Receptor Interactions by Alanine-Scanning Mutagenesis”. Science 244. pp. 1081-85. 1989.
Reidhaar-Olson, et al., “Combinatorial Cassette Mutagenesis as a Probe of the Informational Content of Protein Sequences” Science 241. pp. 53-57. 1988.
Szybalska and Szybalski “Genetics of Human Cell Lines, IV. DNA-Mediated Heritable Transformation of a Biochemical Trait” Proc. Nat. Acad. Sci., USA. vol. 48. pp. 2026-2034. 1962.
Maitland, et al. “Biochemical Transformation of Mouse Cells by Fragments of Herpes Simplex Virus DNA” Cell, vol. 11, pp. 233-241. May 1977.
van der Putten, et al. “Efficient insertion of genes into the mouse germ line via retroviral vectors”. Proc. Natl. Acad. Sci.USA vol. 82. pp. 6148-6152. Sep. 1985.
De Vos, et al . “Human Growth Hormone and Extracellular Domain of Its Receptor: Crystal Structure of the Complex”. Science, vol. 255. pp. 306-312. 1992.
Tsai, et al. “In Vitro Selection of RNA Epitopes Using Autoimmune Patient Serum” The Journal of Immunology. vol. 150. No. 3. pp. 1137-1145. Feb. 1, 1993.
Cull, et al. “Screening for receptor ligands using large libraries of peptides linked to the C terminus of the lac repressor”. Proc. Natl. Acad. Sci. USA vol. 89, pp. 1865-1869. Mar. 1992.
Cho, et al. “An Unnatural Biopolymer” Science. vol. 261. pp. 1303-1307. Sep. 3, 1993.
Simon, et al. “Peptoids: A modular approach to drug discovery”. Proc. Natl. Acad. Sci. USA vol. 89. pp. 9367-9371. Oct. 1992.
Fodor, et al., “Multiplexed biochemical assay with biological chips”. Nature. vol. 364. pp. 555-556. Aug. 5, 1993.
Lam, et al. “A new type of synthetic peptide library for identifying ligand-binding activity”. Nature. vol. 354. pp. 82-84. Nov. 7, 1991.
Gallop, et al. “Applications of Combinatorial Technologies to Drug Discover. 1. Background and Peptide Combinatorial Libraries.” Journal of Medical Chemistry. vol. 37. No. 9. pp. 1233-1251. Apr. 29, 1994.
Scott, et al. “Searching for Peptide Ligands with an Epitope Library”. Science. vol. 249. pp. 386-390. Jul. 27, 1990.
Felici, et al. “Selection of Antibody Ligands from a Large Library of Oligopeptides Expressed on a Multivalent Exposition Vector”. J. Mol. Biol. vol. 222. pp. 301-310. 1991.
Carell, et al., “A Solution-Phase Screening Procedure for the Isolation of Active Compounds from a Library of Molecules”. Angew. Chem. Int. Ed. Engl. vol. 33 No. 20. pp. 2061-2064. 1994.
Carell, et al. “A Novel Procedure for the Synthesis of Libraries Containing Small Organic Molecules”. Angew. Chem. Int. Ed. Engl. vol. 33. No. 20. pp. 2059-2061. 1994.
Tsai, et al. “In vitro selection of an RNA epitope immunologically cross-reactive with a peptide”. Proc. Natl. Acad. Sci.USA. vol. 89. pp. 8864-8868. Oct. 1992.
Lowy, et al. “Isolation of Transforming DNA: Cloning the Hamster aprt Gene”. Cell. vol. 22, pp. 817-823. Dec. 1980.
Wlodaver, et al. “Crystal structure of human recombinant interleukin-4 at 2.25 A resolution” FEBS letters. vol. 309. No. 1. pp. 59-64. Aug. 1992.
Bowie, et al. “Identifying determinants of folding and activity for a protein of unknown structure”. Proc. Natl. Acad. Sci. USA. vol. 86. pp. 2152-2156. Apr. 1989.
Bass, et al. “A systematic mutational analysis of hormone-binding determinants in the human growth hormone receptor”
Deshpande Amit
Hansen Marc F.
Cantor & Colburn LLP
Noble Marcia S.
Paras, Jr. Peter
The University of Connecticut
LandOfFree
Mammalian early developmental regulator gene does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mammalian early developmental regulator gene, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mammalian early developmental regulator gene will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3832119